TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALVO

Alvotech

Healthcare · Drug Manufacturers - Specialty & Generic

5.50$ -3.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Alvotech (ALVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 106 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ALVO
Line item Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
8.0 8.0 8.0 8.0 17 17 17 17 1.2 1.2 0.5 35 0.5 40 19 24 16 4.4 18 53 37 199 103 151 133 173 114 166 106 106 492
– – – – – – – – – – 4.7 – 1.7 16 23 29 39 29 37 56 20 45 40 80 65 74 35 61 46 52 195
8.0 8.0 8.0 8.0 17 17 17 17 1.2 1.2 -4.7 35 -1.3 24 -3.6 -4.9 -23 -24 -19 -3.0 17 154 63 71 67 99 79 105 60 54 297
24 24 24 24 37 37 37 37 45 45 52 44 47 40 41 47 51 49 53 58 50 48 34 40 38 55 52 40 25 22 138
12 12 12 12 15 15 15 15 43 43 20 22 24 115 17 30 22 20 17 18 15 14 17 15 19 27 26 20 26 44 115
-23 -23 -23 -23 255 255 0.0 0.2 88 88 71 20 71 155 59 76 73 68 70 76 65 62 50 57 57 81 78 57 50 65 250
-15 -15 -15 -15 -34 -34 -69 -0.2 -87 -87 -76 15 -72 -131 -62 -81 -96 -93 -89 -79 -48 92 13 13 11 18 1.4 48 9.6 -12 47
24 24 24 24 24 24 24 24 28 28 34 23 20 19 17 119 208 150 44 69 184 42 91 159 36 37 36 41 41 41 159
-52 -52 -52 -52 -73 -73 -137 -9.2 -150 -150 -103 254 -95 -106 -6.3 -344 -306 169 -206 -309 -225 77 -25 -44 93 9.3 -6.0 40 1.0 -67 -32
0.1 0.1 0.1 0.1 -30 -30 -30 -30 -13 -13 -22 0.3 -18 1.1 2.3 -23 -29 -20 -17 -32 -6.4 12 -13 23 -16 -23 -0.8 148 0.0 0.1 147
-52 -52 -52 -52 -43 -43 -43 -9.2 -137 -137 -81 254 -77 -107 -8.6 -321 -276 189 -188 -277 -219 65 -11 -67 110 32 -5.2 -109 1.0 -67 -180
-25 -25 -25 -25 -45 -45 4.1 -0.2 -81 -81 -65 214 -71 -83 16 -219 -92 175 -149 -234 -34 -17 138 -120 137 52 33 -85 52 -1.5 -1.4

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?